Close

Articles Posted in Janssen Pharmaceutical

Updated:

Topamax: Johnson and Johnson, Janssen $11 Million Jury Verdict

Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals unit lost a jury trial in Philadelphia over its drug Topamax. The jury ordered the companies to pay $11 million in a product liability lawsuit which claimed that the anti-seizure drug Topamax caused birth defects. Jury: Failure to Warn Jurors in state court in…

Contact Us
Start Chat